Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis (Q35450437)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis |
scientific article |
Statements
1 reference
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis (English)
1 reference
M Milella
1 reference
F Cuppone
1 reference
S Novello
1 reference
A Ceribelli
1 reference
V Vaccaro
1 reference
A Gelibter
1 reference
G V Scagliotti
1 reference
F Cognetti
1 reference
16 February 2011
1 reference
1 reference
22
1 reference
10
1 reference
2277-2285
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference